Clinical Trials Browser

OTHER_GOV × Lymphoma × Gemcitabine × Clear all

NCT00280878 2016-01-15

Rituximab in Combination With Outpatient Therapy for CD20+ Lymphoma

Phase 2 Completed

Lymphoma, Lymphoma, Non-Hodgkin

NCT00163748 2016-01-08

Efficacy and Treatment Related Toxicity Study of a New Regimen for Lymphoma

Phase 2 Completed

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin

NCT00163761 2016-01-08

Efficacy Study of Outpatient Therapy for Lymphoma

Phase 2 Completed

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin